US 7129052
Peptides and their utility in modulation of behavior of cells expressing α3β1 integrins
granted A61KA61K38/00A61P
Quick answer
US patent 7129052 (Peptides and their utility in modulation of behavior of cells expressing α3β1 integrins) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Oct 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Oct 31 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K38/00, A61P, A61P27/02, A61P29/00